glp 1 anorexia GLP-1 receptor agonists: A novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)? A systematic review Patient Success Story: Transformative Results

Here is a simple guide: Consider Mounjaro if: You want maximum weight loss results You have both obesity and type 2 diabetes You are comfortable with a higher monthly cost You want faster visible results (noticeable from month 2 in many patients) Consider Ozempic if: Budget is a key consideration You have cardiovascular disease (Ozempic has specific heart-protective approvals) You are starting with a lower dose and want to see how your body responds You prefer a medication with a longer track record globally In both cases, you need: A valid prescription from a qualified doctor Regular monitoring and follow-up consultations A structured diet and lifestyle plan alongside the medication Why Doctor Supervision Matters in India Both Mounjaro and Ozempic are Schedule H prescription drugs in India

Confirm drug coverage : Not every GLP1 medication is included

Shields integrated specialty pharmacy care model minimizes these inefficiencies

What is new is the growing pile of evidence suggesting that activating those receptors, even at very low doses, can quiet the overactive immune response that defines conditions like rheumatoid arthritis , psoriasis, Hashimoto thyroiditis, and inflammatory bowel disease

Foods to avoid on semaglutide include high-fat fried foods, excessively sugary items, and carbonated beverages

With more anterior COM, the center of pressure under the foot shifts and loading patterns change, increasing shear stresses and risk for plantar pain and lower-extremity injuries